Literature DB >> 25375955

Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011.

Earl S Ford1.   

Abstract

BACKGROUND: Numbers and rates of hospitalizations and ED visits by patients with COPD are important metrics for surveillance purposes. The objective of this study was to examine trends in these rates from 2001 to 2012 among adults aged ≥ 18 years in the United States.
METHODS: Data from the Nationwide Inpatient Sample (NIS) and Nationwide Emergency Department Sample (NEDS) were examined for temporal trends in the numbers and rates of hospitalizations by patients with COPD or bronchiectasis, mean length of stay, in-hospital case-fatality rate, 30-day readmission rate, and numbers and rates of ED visits.
RESULTS: The national number of discharges with COPD or bronchiectasis as the principal diagnosis was about 88,000 higher in 2012 than in 2001, but the age-adjusted rate of discharges did not change significantly (range, 242.7-286.0 per 100,000 population, P trend = .554). In contrast, hospitalization rates for common cardiovascular disorders, pneumonia, and lung cancer decreased significantly by 27% to 68%, whereas the mean charge doubled and mean cost increased by 40%. From 2006 to 2011, the numbers of ED visits increased from 1,480,363 to 1,787,612. The age-adjusted rate increased nonsignificantly from 654 to 725 per 100,000 population (P trend = .072).
CONCLUSIONS: Despite many local and national efforts to reduce the burden of COPD, total hospitalizations and ED visits over the past decade have increased for COPD, and the age-adjusted rates of hospitalizations and ED visits for COPD or bronchiectasis have not changed significantly in the United States.

Entities:  

Mesh:

Year:  2015        PMID: 25375955      PMCID: PMC4589247          DOI: 10.1378/chest.14-2146

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  25 in total

1.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

2.  Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020.

Authors:  Earl S Ford; Louise B Murphy; Olga Khavjou; Wayne H Giles; James B Holt; Janet B Croft
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

3.  Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.

Authors:  Roozbeh Sharif; Trisha M Parekh; Karen S Pierson; Yong-Fang Kuo; Gulshan Sharma
Journal:  Ann Am Thorac Soc       Date:  2014-06

4.  Temporal trends in chronic obstructive lung disease case fatality in hospitalized US veterans: 1970-1987.

Authors:  I B Tager; M R Segal
Journal:  Chest       Date:  1991-05       Impact factor: 9.410

5.  Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease.

Authors:  Gulshan Sharma; Yong-Fang Kuo; Jean L Freeman; Dong D Zhang; James S Goodwin
Journal:  Arch Intern Med       Date:  2010-10-11

6.  Mortality trends during a program that publicly reported hospital performance.

Authors:  David W Baker; Doug Einstadter; Charles L Thomas; Scott S Husak; Nahida H Gordon; Randall D Cebul
Journal:  Med Care       Date:  2002-10       Impact factor: 2.983

7.  Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department.

Authors:  Adit A Ginde; Chu-Lin Tsai; Phillip G Blanc; Carlos A Camargo
Journal:  Jt Comm J Qual Patient Saf       Date:  2008-11

8.  The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease.

Authors:  Colin R Cooke; Min J Joo; Stephen M Anderson; Todd A Lee; Edmunds M Udris; Eric Johnson; David H Au
Journal:  BMC Health Serv Res       Date:  2011-02-16       Impact factor: 2.655

9.  Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: analysis of hospital admission records.

Authors:  Frank W K Chan; Fiona Y Y Wong; Carrie H K Yam; Wai-ling Cheung; Eliza L Y Wong; Michael C M Leung; William B Goggins; Eng-kiong Yeoh
Journal:  BMC Health Serv Res       Date:  2011-08-10       Impact factor: 2.655

10.  Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study.

Authors:  Peter A Coventry; Isla Gemmell; Christopher J Todd
Journal:  BMC Pulm Med       Date:  2011-11-04       Impact factor: 3.317

View more
  46 in total

1.  Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Authors:  Ian G Stiell; Jeffrey J Perry; Catherine M Clement; Robert J Brison; Brian H Rowe; Shawn D Aaron; Andrew D McRae; Bjug Borgundvaag; Lisa A Calder; Alan J Forster; Jennifer Brinkhurst; George A Wells
Journal:  CMAJ       Date:  2018-12-03       Impact factor: 8.262

2.  Association Between Insurance Status and Access to Hospital Care in Emergency Department Disposition.

Authors:  Arjun K Venkatesh; Shih-Chuan Chou; Shu-Xia Li; Jennie Choi; Joseph S Ross; Gail D'Onofrio; Harlan M Krumholz; Kumar Dharmarajan
Journal:  JAMA Intern Med       Date:  2019-05-01       Impact factor: 21.873

3.  Successful Use of Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease. How Do High-Performing Hospitals Do It?

Authors:  Kimberly A Fisher; Kathleen M Mazor; Sarah Goff; Mihaela S Stefan; Penelope S Pekow; Lauren A Williams; Vida Rastegar; Michael B Rothberg; Nicholas S Hill; Peter K Lindenauer
Journal:  Ann Am Thorac Soc       Date:  2017-11

4.  Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease.

Authors:  Chien-Wen Tseng; Jinoos Yazdany; R Adams Dudley; Colette DeJong; Dhruv S Kazi; Randi Chen; Grace A Lin
Journal:  JAMA Intern Med       Date:  2017-04-01       Impact factor: 21.873

5.  Accuracy of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data: A Systematic Review.

Authors:  Kari R Gillmeyer; Ming-Ming Lee; Alissa P Link; Elizabeth S Klings; Seppo T Rinne; Renda Soylemez Wiener
Journal:  Chest       Date:  2018-11-22       Impact factor: 9.410

6.  Informing management on the future structure of hospital care: an extrapolation of trends in demand and costs in lung diseases.

Authors:  Matthias Vogl; Reiner Leidl
Journal:  Eur J Health Econ       Date:  2015-06-02

7.  A Multidimensional Risk Score to Predict All-Cause Hospitalization in Community-Dwelling Older Individuals With Obstructive Lung Disease.

Authors:  Rosanne J H C G Beijers; Bram van den Borst; Anne B Newman; Sachin Yende; Stephen B Kritchevsky; Patricia A Cassano; Douglas C Bauer; Tamara B Harris; Annemie M W J Schols
Journal:  J Am Med Dir Assoc       Date:  2016-02-23       Impact factor: 4.669

8.  Incidence of Acute Cardiovascular Event After Acute Exacerbation of COPD.

Authors:  Tadahiro Goto; Yuichi J Shimada; Mohammad Kamal Faridi; Carlos A Camargo; Kohei Hasegawa
Journal:  J Gen Intern Med       Date:  2018-06-08       Impact factor: 5.128

9.  Individualized prediction of lung-function decline in chronic obstructive pulmonary disease.

Authors:  Zafar Zafari; Don D Sin; Dirkje S Postma; Claes-Göran Löfdahl; Judith Vonk; Stirling Bryan; Stephen Lam; C Martin Tammemagi; Rahman Khakban; S F Paul Man; Donald Tashkin; Robert A Wise; John E Connett; Bruce McManus; Raymond Ng; Zsuszanna Hollander; Mohsen Sadatsafavi
Journal:  CMAJ       Date:  2016-08-02       Impact factor: 8.262

10.  Obstructive and Restrictive Lung Function Measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012.

Authors:  Sankar D Navaneethan; Sreedhar Mandayam; Susana Arrigain; Mahboob Rahman; Wolfgang C Winkelmayer; Jesse D Schold
Journal:  Am J Kidney Dis       Date:  2016-04-27       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.